Your browser doesn't support javascript.
loading
Defining the genotypic and phenotypic spectrum of X-linked MSL3-related disorder.
Brunet, Theresa; McWalter, Kirsty; Mayerhanser, Katharina; Anbouba, Grace M; Armstrong-Javors, Amy; Bader, Ingrid; Baugh, Evan; Begtrup, Amber; Bupp, Caleb P; Callewaert, Bert L; Cereda, Anna; Cousin, Margot A; Del Rey Jimenez, Juan C; Demmer, Laurie; Dsouza, Nikita R; Fleischer, Nicole; Gavrilova, Ralitza H; Ghate, Sumedha; Graf, Elisabeth; Green, Andrew; Green, Sarah R; Iascone, Maria; Kdissa, Ameni; Klee, Dirk; Klee, Eric W; Lancaster, Emily; Lindstrom, Kristin; Mayr, Johannes A; McEntagart, Meriel; Meeks, Naomi J L; Mittag, Dana; Moore, Harrison; Olsen, Anne K; Ortiz, Damara; Parsons, Gretchen; Pena, Loren D M; Person, Richard E; Punj, Sumit; Ramos-Rivera, Gonzalo Alonso; Sacoto, Maria J Guillen; Bradley Schaefer, G; Schnur, Rhonda E; Scott, Tiana M; Scott, Daryl A; Serbinski, Carolyn R; Shashi, Vandana; Siu, Victoria M; Stadheim, Barbro Fossøy; Sullivan, Jennifer A; Svantnerová, Jana.
Afiliación
  • Brunet T; Institute of Human Genetics, Technical University Munich, Munich, Germany. theresa.brunet@mri.tum.de.
  • McWalter K; GeneDx, Inc., Gaithersburg, MD, USA.
  • Mayerhanser K; Institute of Human Genetics, Technical University Munich, Munich, Germany.
  • Anbouba GM; Division of Genetics and Metabolism, Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Armstrong-Javors A; Department of Pediatric Neurology, Massachusetts General Hospital, Boston, MA, USA.
  • Bader I; Department of Clinical Genetics, University Children's Hospital, Paracelsus Medical University, Salzburg, Austria.
  • Baugh E; Institute for Genomic Medicine, Columbia University, New York, NY, USA.
  • Begtrup A; GeneDx, Inc., Gaithersburg, MD, USA.
  • Bupp CP; Medical Genetics, Spectrum Health and Helen DeVos Children's Hospital, Grand Rapids, MI, USA.
  • Callewaert BL; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI, USA.
  • Cereda A; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
  • Cousin MA; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Del Rey Jimenez JC; Department of Pediatrics, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Demmer L; Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
  • Dsouza NR; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Fleischer N; St George's Genomics Service, St George's University Hospitals NHS FT, London, UK.
  • Gavrilova RH; Medical Genetics, Atrium Health Levine Children's Hospital, Charlotte, NC, USA.
  • Ghate S; Bioinformatics Research and Development Laboratory, Genomics Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Graf E; FDNA Inc., Boston, MA, USA.
  • Green A; Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
  • Green SR; Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA.
  • Iascone M; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Kdissa A; St Vincent Hospital Medical Genetics Clinic, Green Bay, WI, USA.
  • Klee D; Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
  • Klee EW; Department of Clinical Genetics, Children's Health Ireland at Crumlin, Dublin, Ireland.
  • Lancaster E; University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Springdale, AR, USA.
  • Lindstrom K; Laboratorio di Genetica Medica, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Mayr JA; CENTOGENE AG, Rostock, Germany.
  • McEntagart M; Department of Diagnostic and Interventional Radiology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Meeks NJL; Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
  • Mittag D; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Moore H; Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA.
  • Olsen AK; UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Ortiz D; Division of Genetics and Metabolism, Phoenix Children's Hospital, Phoenix, AZ, USA.
  • Parsons G; Department of Pediatrics, Salzburger Landeskliniken and Paracelsus Medical University, Salzburg, Austria.
  • Pena LDM; Medical Genetics, St George's University Hospitals NHS FT, London, UK.
  • Person RE; Department of Pediatrics, Section of Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Punj S; Medical Genetics, Atrium Health Levine Children's Hospital, Charlotte, NC, USA.
  • Ramos-Rivera GA; INTEGRIS Pediatric Specialties/Medical Genetics, Oklahoma City, OK, USA.
  • Sacoto MJG; Department of Pediatric, Soerlandet Sykehus Kristiansand, Kristiansand, Norway.
  • Bradley Schaefer G; UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Schnur RE; Medical Genetics, Spectrum Health and Helen DeVos Children's Hospital, Grand Rapids, MI, USA.
  • Scott TM; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Scott DA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Serbinski CR; GeneDx, Inc., Gaithersburg, MD, USA.
  • Shashi V; GeneDx, Inc., Gaithersburg, MD, USA.
  • Siu VM; Department of Pediatric Neurology, National Institute of Children's Diseases, Bratislava, Slovakia.
  • Stadheim BF; GeneDx, Inc., Gaithersburg, MD, USA.
  • Sullivan JA; University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Springdale, AR, USA.
  • Svantnerová J; GeneDx, Inc., Gaithersburg, MD, USA.
Genet Med ; 23(2): 384-395, 2021 02.
Article en En | MEDLINE | ID: mdl-33173220
ABSTRACT

PURPOSE:

We sought to delineate the genotypic and phenotypic spectrum of female and male individuals with X-linked, MSL3-related disorder (Basilicata-Akhtar syndrome).

METHODS:

Twenty-five individuals (15 males, 10 females) with causative variants in MSL3 were ascertained through exome or genome sequencing at ten different sequencing centers.

RESULTS:

We identified multiple variant types in MSL3 (ten nonsense, six frameshift, four splice site, three missense, one in-frame-deletion, one multi-exon deletion), most proven to be de novo, and clustering in the terminal eight exons suggesting that truncating variants in the first five exons might be compensated by an alternative MSL3 transcript. Three-dimensional modeling of missense and splice variants indicated that these have a deleterious effect. The main clinical findings comprised developmental delay and intellectual disability ranging from mild to severe. Autism spectrum disorder, muscle tone abnormalities, and macrocephaly were common as well as hearing impairment and gastrointestinal problems. Hypoplasia of the cerebellar vermis emerged as a consistent magnetic resonance image (MRI) finding. Females and males were equally affected. Using facial analysis technology, a recognizable facial gestalt was determined.

CONCLUSION:

Our aggregated data illustrate the genotypic and phenotypic spectrum of X-linked, MSL3-related disorder (Basilicata-Akhtar syndrome). Our cohort improves the understanding of disease related morbidity and allows us to propose detailed surveillance guidelines for affected individuals.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trastorno del Espectro Autista / Discapacidad Intelectual Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Genet Med Asunto de la revista: GENETICA MEDICA Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trastorno del Espectro Autista / Discapacidad Intelectual Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Genet Med Asunto de la revista: GENETICA MEDICA Año: 2021 Tipo del documento: Article